Toggle light / dark theme

“It was either die or do this transplant. I want to live. I know it’s a shot in the dark, but it’s my last choice,” said Bennett.

The heart was provided by Revivicor, a company based in Virginia that has been engineering pig organs for roughly two decades. In several experiments for pig-to-baboon transplants, the organs survived up to nine months, until the animals passed away due to a lung infection unrelated to the transplant.

Overall, the heart had 10 hefty genetic edits. Three of them wiped out sugar molecules on the outside of cells that provoke an immune response. Six bolstered the chance of the human host accepting the heart—amping up an anti-inflammatory response, preventing blood vessel damage, and dampening any antibodies against the organ. Finally, the last edit limited the pig heart’s size. Although it generally matched the size of a human heart, the team wanted to prevent the pig organ from overgrowth inside Bennett’s chest once it was transplanted—something they previously noticed happened in baboons.

And it took less than a full workday. Stanford Medicine scientists and their collaborators have engineered a new genome sequencing technique that can diagnose rare genetic diseases in an average of eight hours. This is a record-breaking time frame that is leap and bounds ahead of other current advanced technologies.


Gene sequencing is crucial to advancing science! Check out why cutting time and cost is key.

Circa 2019


The race to engineer the next-generation banana is on. The Colombian government confirmed last month that a banana-killing fungus has invaded the Americas — the source of much of the world’s banana supply. The invasion has given new urgency to efforts to create fruit that can withstand the scourge.

Scientists are using a mix of approaches to save the banana. A team in Australia has inserted a gene from wild bananas into the top commercial variety — known as the Cavendish — and are currently testing these modified bananas in field trials. Researchers are also turning to the powerful, precise gene-editing tool CRISPR to boost the Cavendish’s resilience against the fungus, known as Fusarium wilt tropical race 4 (TR4).

Breeding TR4 resistance into the Cavendish using conventional methods isn’t possible because the variety is sterile and propagated by cloning. So the only way to save the Cavendish may be to tweak its genome, says Randy Ploetz, a plant pathologist at the University of Florida in Homestead. The variety accounts for 99% of global banana shipments.

Lex Fridman Podcast full episode: https://www.youtube.com/watch?v=jhKZIq3SlYE
Please support this podcast by checking out our sponsors:
- Onnit: https://lexfridman.com/onnit to get up to 10% off.
- Clear: https://clearme.com/lexpod and use code LexPod to get 2 months free.
- National Instruments (NI): https://www.ni.com/perspectives.
- SimpliSafe: https://simplisafe.com/lex and use code LEX to get a free security camera.
- Linode: https://linode.com/lex to get $100 free credit.

GUEST BIO:
David Sinclair is a geneticist at Harvard and author of Lifespan.

PODCAST INFO:
Podcast website: https://lexfridman.com/podcast.
Apple Podcasts: https://apple.co/2lwqZIr.
Spotify: https://spoti.fi/2nEwCF8
RSS: https://lexfridman.com/feed/podcast/
Full episodes playlist: https://www.youtube.com/playlist?list=PLrAXtmErZgOdP_8GztsuKi9nrraNbKKp4
Clips playlist: https://www.youtube.com/playlist?list=PLrAXtmErZgOeciFP3CBCIEElOJeitOr41

SOCIAL:

Church points to factors that helped make such a success of three of the top COVID-19 vaccine technologies. For one thing, they all used gene therapy technologies, and each was a new method relative to the past and to each other. For instance, the AstraZeneca vaccine was based on an adenovirus capsid containing double-stranded DNA as opposed to an adeno-associated virus (AAV) of the Johnson & Johnson/Janssen vaccine, while the Moderna and Pfizer/BioNTech vaccines were based on single-stranded mRNA inside lipid nanoparticles.

“Implementation science is the unsung handmaiden of biomedical discovery!”

Secondly, each of them was approved by the FDA 10 times faster than the vast majority of therapeutic products, and finally, the cost per vaccine has been as low as $2 per dose for the United Nations’ COVAX global access program. That’s about a million times cheaper than Zolgensma, he says, referring to the AAV gene therapy medication used to treat spinal muscular atrophy. So since “any one of these could spark a revolution,” according to Church, imagine what could happen in the next 12 months if all four factors pertain again?

After only 23 minutes, he could even pee again!

Researchers at the University of Alabama at Birmingham transplanted kidneys derived from genetically modified pigs into a brain-dead person last year as part of human preclinical trials, Science Daily reported.

Organ transplant from another species recently made big news, a heart from a genetically modified pig was transplanted into a human whose heart condition left with no other option. While the transplant was authorized under compassionate grounds by the U.S. Food and Drug Administration, the idea is catching up with the provider of the organ, Revivicor, already having completed two such trials in dead patients.

As Science Daily explains, genetically modified kidneys have been extensively tested in non-human primate recipients but testing them in humans before clinical trials can also provide important information about the safety and efficacy of the transplanted organs.

Full Story:

The latest episode of the Huberman Lab Podcast is all about the aging process and how to slow, halt or reverse it. My guest is Dr. David Sinclair from Harvard Medical School.

We discuss:

• Epigenetics.
• Fasting, breaking fasts.
• Nutrition, artificial sweeteners.
• How puberty impacts aging.
• Resveratrol, caffeine, electrolytes.
• NAD, NMN, Metformin, Berberine.
• Specific supplementation protocols.

Genetically modified crops have a bad rep. How could something so unnatural be good for us?

Well, we finally get to hear from the plants themselves. New evidence shows that plants have been genetically modifying themselves — and the process, called lateral gene transfer, could lead to new plants that are resilient to climate change.

The research: We all know that genes are transferred from parent to offspring. The same is true for all species, including plants. Some bacteria can swap genes with each other, but more complex life (usually) stays in its lane.